surmount-1 tirzepatide obesity nejm 2022 weight loss percent SURPASS-2 (NEJM 2021) was the definitive head-to-head: vs semaglutide 1.0 mg (the maximum approved T2DM dose) in 1,879 patients with type 2 diabetes. All three tirzepatide doses produced superior HbA1c reductions Tirzepatide versus Semaglutide Once Weekly

AD targets more women than men

One of the questions our providers hear most often is: The honest answer is that everyone responds differently

As a physician double board-certified in Obesity Medicine and Primary Care, Dr

However, the review stresses that direct attribution of these effects to GLP-1R-mediated anti-inflammatory pathways remains to be conclusively demonstrated

Fatima S, Braunberger T, Mohammad TF, Kohli I, Hamzavi IH

Common signs include: Dizziness or lightheadedness Extreme drowsiness or sedation Slow or irregular heartbeat Low blood pressure, which can cause fainting Confusion or difficulty staying awake Dry mouth and weakness In severe cases, respiratory depression or coma These symptoms occur because clonidine depresses the central nervous system and cardiovascular system